An analysis of the Dutch AmPrEP study of HIV pre-exposure prophylaxis (PrEP) of participants who took event-driven instead of daily PrEP has found that users’ accounts of their PrEP usage, and whether they took it at times of HIV risk, were reliable and were corroborated by drug level measurements. This shows that in this population at least,… Read More »
“I’m a dope fiend, so my priority is to get dope … Living while homeless in an active addiction–especially as a woman– PrEP just isn’t my priority. My priority is to get well. My second is to get my ass washed. My last thought is PrEP”. A qualitative study among women who inject drugs in… Read More »
There are significant gaps in the provision of STI testing services in PrEP programmes, according to research published in the Journal of the International AIDS Society. Analysis of 91 separate programmes showed that 30% were not routinely testing for STIs either before treatment was started or at regular intervals thereafter. Screening rates were higher in… Read More »
High initiation and persistence on pre-exposure prophylaxis (PrEP) has been documented in pregnant women in Cape Town, South Africa, with 91% of those offered PrEP starting it and nearly half of those continuing to take PrEP six months later. While women who had given birth and those reporting side effects were less likely to stay… Read More »